ArticleJournal of pharmaceutical analysis2024

Targeted delivery of rosuvastatin enhances treatment of hyperhomocysteinemia-induced atherosclerosis using macrophage membrane-coated nanoparticles.

Dayue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.